OSTX
OS Therapies Incorporated Common Stock
$1.840+-0.000 (-0.000%)
Precio en Tiempo Real
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$1.840
Máximo
$1.840
Mínimo
$1.840
Volumen
0.08M
Fundamentos de la Empresa
Estadísticas de Negociación
Noticias Relacionadas
PR Newswire
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...
Ver más
Analyst Upgrades
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.
Ver más
BusinessWire
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.